Of 5 frequently amplified p53 pathway genes in FL-HCC, 4 (IFR2BP2, DUSP1, TXNIP, and MCL1) were altered in the expected direction to result in decreased p53 function. This evidence concerns the gene MCL1 and hepatocellular carcinoma.